Search Results - "Karatas, Hacer"

Refine Results
  1. 1

    High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein–Protein Interaction by Karatas, Hacer, Townsend, Elizabeth C, Cao, Fang, Chen, Yong, Bernard, Denzil, Liu, Liu, Lei, Ming, Dou, Yali, Wang, Shaomeng

    Published in Journal of the American Chemical Society (16-01-2013)
    “…Mixed lineage leukemia 1 (MLL1) is a histone H3 lysine 4 (H3K4) methyltransferase, and targeting the MLL1 enzymatic activity has been proposed as a novel…”
    Get full text
    Journal Article
  2. 2

    Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia by Cao, Fang, Townsend, Elizabeth C., Karatas, Hacer, Xu, Jing, Li, Li, Lee, Shirley, Liu, Liu, Chen, Yong, Ouillette, Peter, Zhu, Jidong, Hess, Jay L., Atadja, Peter, Lei, Ming, Qin, Zhaohui S., Malek, Sami, Wang, Shaomeng, Dou, Yali

    Published in Molecular cell (23-01-2014)
    “…Here we report a comprehensive characterization of our recently developed inhibitor MM-401 that targets the MLL1 H3K4 methyltransferase activity. MM-401 is…”
    Get full text
    Journal Article
  3. 3

    Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors by Olgen, Sureyya, Kaleli, Sevde Nur Biltekin, Karaca, Banu Taktak, Demirel, Ural U, Bristow, Hacer Karatas

    Published in Current medicinal chemistry (01-01-2024)
    “…Recent studies showed that the cooperation between c-SRC and EGFR is responsible for more aggressive phenotype in diverse tumors, including glioblastomas and…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Structure-Based Design of High-Affinity Macrocyclic Peptidomimetics to Block the Menin-Mixed Lineage Leukemia 1 (MLL1) Protein–Protein Interaction by Zhou, Haibin, Liu, Liu, Huang, Jing, Bernard, Denzil, Karatas, Hacer, Navarro, Alexandro, Lei, Ming, Wang, Shaomeng

    Published in Journal of medicinal chemistry (14-02-2013)
    “…Menin is an essential oncogenic cofactor for mixed lineage leukemia 1 (MLL1)-mediated leukemogenesis through its direct interaction with MLL1. Targeting the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    An economical and practical procedure of favipiravir synthesis for the treatment of Covid-19 by Karatas, Hacer, Hanashalshahaby, Essam Hamied Ahmed, Catal, Unal, Butun, Yasar Enes, Kurt, Elif, Gursel, Sahin, Kaya, Adil, Guzel, Mustafa

    Published in Chemical papers (01-03-2023)
    “…Favipiravir is a wide-spectrum antiviral generic drug that has received large attention during the recent COVID-19 pandemic. While there are synthetic…”
    Get full text
    Journal Article
  9. 9

    MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program by Xu, Jing, Li, Li, Xiong, Jie, denDekker, Aaron, Ye, Andrew, Karatas, Hacer, Liu, Liu, Wang, He, Qin, Zhaohui S, Wang, Shaomeng, Dou, Yali

    Published in Cell discovery (17-05-2016)
    “…Mixed lineage leukemia protein-1 (MLL1) has a critical role in human MLL1 rearranged leukemia ( MLLr ) and is a validated therapeutic target. However, its role…”
    Get full text
    Journal Article
  10. 10

    Synthesis and Potent Antimicrobial Activity of Some Novel 4-(5, 6-Dichloro-1H-benzimidazol-2-yl)-N-substituted Benzamides by Ozden, Seçkin, Karataş, Hacer, Yildiz, Sulhiye, Göker, Hakan

    Published in Archiv der Pharmazie (Weinheim) (01-10-2004)
    “…A series of 4‐(5, 6‐dichloro‐1H‐benzimidazol‐2‐yl)‐N‐substituted benzamides were synthesized and evaluated for antibacterial and antifungal activities against…”
    Get full text
    Journal Article
  11. 11

    In Vivo Molecular Bioluminescence Imaging: New Tools and Applications by Mezzanotte, Laura, van ‘t Root, Moniek, Karatas, Hacer, Goun, Elena A, Löwik, Clemens W.G.M

    Published in Trends in biotechnology (Regular ed.) (01-07-2017)
    “…in vivo bioluminescence imaging (BLi) is an optical molecular imaging technique used to visualize molecular and cellular processes in health and diseases and…”
    Get full text
    Journal Article
  12. 12

    Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming by Guo, Yijing, Lei, Ienglam, Tian, Shuo, Gao, Wenbin, Hacer, Karatas, Li, Yangbing, Wang, Shaomeng, Liu, Liu, Wang, Zhong

    Published in The Journal of biological chemistry (07-06-2019)
    “…Reprogramming of fibroblasts into induced cardiomyocytes (iCMs) is a potentially promising strategy for regenerating a damaged heart. However, low…”
    Get full text
    Journal Article
  13. 13

    Synthesis and Potent In vitro Activity of Novel 1H-Benzimidazoles as Anti-MRSA Agents by Karataş, Hacer, Alp, Mehmet, Yıldız, Sulhiye, Göker, Hakan

    Published in Chemical biology & drug design (01-08-2012)
    “…A new class of 1H‐benzimidazolecarboxamidines was synthesized and evaluated for in vitro antibacterial and antifungal activities, including drug‐resistant…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Identification of Quinolinols as Activators of TEAD-Dependent Transcription by Pobbati, Ajaybabu V, Mejuch, Tom, Chakraborty, Sayan, Karatas, Hacer, Bharath, Sakshibeedu R, Guéret, Stéphanie M, Goy, Pierre-Alexis, Hahne, Gernot, Pahl, Axel, Sievers, Sonja, Guccione, Ernesto, Song, Haiwei, Waldmann, Herbert, Hong, Wanjin

    Published in ACS chemical biology (20-12-2019)
    “…The transcriptional co-regulators YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif) are the vertebrate downstream…”
    Get full text
    Journal Article
  17. 17

    Analysis of the Binding of Mixed Lineage Leukemia 1 (MLL1) and Histone 3 Peptides to WD Repeat Domain 5 (WDR5) for the Design of Inhibitors of the MLL1−WDR5 Interaction by Karatas, Hacer, Townsend, Elizabeth C, Bernard, Denzil, Dou, Yali, Wang, Shaomeng

    Published in Journal of medicinal chemistry (22-07-2010)
    “…MLL1 is a histone 3 lysine 4 (H3K4) methyltransferase and a promising new cancer therapeutic target. The catalytic activity of MLL1 is regulated by the…”
    Get full text
    Journal Article
  18. 18

    MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency by Zhang, Hui, Gayen, Srimonta, Xiong, Jie, Zhou, Bo, Shanmugam, Avinash K., Sun, Yuqing, Karatas, Hacer, Liu, Liu, Rao, Rajesh C., Wang, Shaomeng, Nesvizhskii, Alexey I., Kalantry, Sundeep, Dou, Yali

    Published in Cell stem cell (07-04-2016)
    “…The interconversion between naive and primed pluripotent states is accompanied by drastic epigenetic rearrangements. However, it is unclear whether intrinsic…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Real-Time Imaging and Quantification of Peptide Uptake in Vitro and in Vivo by Karatas, Hacer, Maric, Tamara, D’Alessandro, Pier Luca, Yevtodiyenko, Aleksey, Vorherr, Thomas, Hollingworth, Gregory J, Goun, Elena A

    Published in ACS chemical biology (18-10-2019)
    “…Peptides constitute an important class of drugs for the treatment of multiple metabolic, oncological, and neurodegenerative diseases, and several hundred novel…”
    Get full text
    Journal Article